IPEC: Risk Assessment Guide for Excipients now available
The new version 1 of the "IPEC Risk Assessment Guide for Pharmaceutical Excipients - Risk Assessment for Excipient Manufacturers (Version 1, 2025)" has just been published on the website of the IPEC (International Pharmaceutical Excipients Council Europe (IPEC Europe)). This guide has been available to IPEC members in the members' area since May 2025 only and can now be accessed under "Resources" in the "Guidelines" section.
The table of contents of version 1 of the new guide published in 2025 includes the following chapters, with chapters 1, 2, and 4 containing further subchapters and subsections. This is an overview of the main chapters:
ACKNOWLEDGEMENTS
1 INTRODUCTION
2 PRINCIPLES OF RISK ASSESSMENT AND MANAGEMENT
3 RISK ASSESSMENT METHODS
4 RISK ASSESSMENT BY EXCIPIENT MANUFACTURER
5 REFERENCES
The full version 1 of the "IPEC Risk Assessment Guide for Pharmaceutical Excipients - Risk Assessment for Excipient Manufacturers (Version 1, 2025)" can be found on the IPEC website.
Related GMP News
02.11.2026Reprotoxic and Persistent: ECHA Committee Recommends New Classification for TFA
28.10.2026IPEC Publishes Version 3 of the Excipient Composition Guide
28.10.2026EMA and CMDh Expand List of Nitrosamine Limits
14.10.2026EMA Reports inconsistent Progress in International API Inspection Cooperation
23.09.2026FDA Warning Letter: serious GMP Deficiencies at a Chinese API Manufacturer
16.09.2026PFAS restriction: Commission highlights Importance of critical Medical Applications



